Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults

ClinicalTrials.gov ID: NCT04845178

Public ClinicalTrials.gov record NCT04845178. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 5:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2 Study of ABP-450 (prabotulinumtoxinA) Purified Neurotoxin Complex for the Prevention of Migraine Headache

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This Phase 2 trial will evaluate the efficacy and safety of ABP-450 for migraine prevention in adults who suffer from six or more migraine days per month. The study will enroll 765 patients across approximately 64 sites in the United States, Canada and Australia. Study subjects will be divided evenly across a low dose group, a high dose group and a placebo group. All patients will receive two treatment cycles of ABP-450 or placebo utilizing the Company's novel injection paradigm.

Study identification

NCT ID
NCT04845178
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AEON Biopharma, Inc.
Industry
Enrollment
797 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 1, 2021 (Actual)
Primary completion
Jun 19, 2024 (Actual)
Completion
Aug 6, 2024 (Actual)
Last update posted
Sep 4, 2024

2021 – 2024

United States locations

U.S. sites
54
U.S. states
24
U.S. cities
52
Facility City State ZIP Site status
MDFirst Research Chandler Arizona 85226 —
Elite Clinical Studies, LLC Phoenix Arizona 85018 —
Arizona Neuroscience Research Phoenix Arizona 85032 —
Clinical Research Consortium Arizona Tempe Arizona 85281 —
Axiom Research LLC Colton California 92324 —
Velocity Research San Diego La Mesa California 91942 —
Collaborative Neuroscience Research Long Beach California 90806 —
Los Angeles Headache Center Los Angeles California 90067 —
Anderson Clinical Research Redlands California 92374 —
Artemis Institute For Clinical Research LLC - San Diego - ClinEdge - PPDS San Diego California 92103 —
Delta Waves LLC - Hunt - PPDS Colorado Springs Colorado 80918 —
Paradigm Clinical Research Centers Wheat Ridge Colorado 80033 —
New England Institute for Neurology and Headache Stamford Connecticut 06905 —
Quality Research of South Florida Hialeah Florida 33016 —
Sandhill Research, LLC Lake Mary Florida 32746 —
Canvas Clinical Research Lake Worth Florida 33467 —
BioMed Research Institute, INC Miami Florida 33126 —
Medical Research Center, LLC Miami Florida 33144 —
Renstar Medical Research Ocala Florida 34470 —
Innovation Medical Research Center Palmetto Bay Florida 33157 —
Clinical Research of Central Florida - ClinEdge - PPDS Winter Haven Florida 33810 —
NeuroTrials Research Inc. - Clinedge - PPDS Atlanta Georgia 30328 —
Drug Studies America, Inc Marietta Georgia 30060 —
Velocity Clinical Research - Boise - ERN - PPDS Meridian Idaho 83642 —
Cedar Crosse Research Center Chicago Illinois 60607 —
Kansas Institute of Research, LLC Overland Park Kansas 66211 —
Crescent City Headache and Neurology Center Chalmette Louisiana 70043 —
Tandem Clinical Research Marrero Louisiana 70072 —
Boston Clinical Trials Inc Boston Massachusetts 02131 —
MedVadis Research Waltham Massachusetts 02451 —
Quest Research Institute - Hunt - PPDS Farmington Hills Michigan 40825 —
Henry Ford Allegiance Neurology Jackson Michigan 49201 —
StudyMetrix Research, LLC City of Saint Peters Missouri 63303 —
Clinvest Research LLC Springfield Missouri 65810 —
Barrett Clinic, P.C. - Clinedge - PPDS La Vista Nebraska 68128 —
Quality Clinical Research Omaha Nebraska 68114 —
Wake Research - CRCN, LLC Las Vegas Nevada 89118 —
Hassman Research Institute - ClinEdge - PPDS Berlin New Jersey 08009 —
Albuquerque Clinical Trials Inc Albuquerque New Mexico 87102 —
Dent Neurologic Institute Amherst New York 14226 —
New York Neurology Associates New York New York 10003 —
Upstate Clinical Research Associates LLC Williamsville New York 14221 —
Dayton Center for Neurological Disorders Centerville Ohio 45459 —
META Medical Research Institute, LLC Dayton Ohio 45432 —
Centricity Research Dublin Multispecialty Dublin Ohio 43016 —
The Orthopedic Foundation New Albany Ohio 43054 —
Thomas Jefferson University, Jefferson Headache Center Philadelphia Pennsylvania 19107 —
Preferred Primary Care Physicians Pittsburgh Pennsylvania 15236 —
WR-ClinSearch Chattanooga Tennessee 37421 —
Bryant Research Group Nashville Tennessee 37203 —
DCT - Baxter LLC dba Discovery Clinical Trials Dallas Texas 75225 —
Mercury Clinical Research Incorporated Sugar Land Texas 77478 —
Aspen Clinical Research LLC - Clinedge - PPDS Orem Utah 84058 —
Northwest Clinical Research Center Bellevue Washington 98004 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04845178, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 4, 2024 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04845178 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →